In silico pharmacology for drug discovery

Similar documents
Receptor Based Drug Design (1)

Structural biology and drug design: An overview

TRAINING REAXYS MEDICINAL CHEMISTRY

Introduction to Chemoinformatics and Drug Discovery

Principles of Drug Design

Molecular Interactions F14NMI. Lecture 4: worked answers to practice questions

Principles of Drug Design

Plan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.

Docking. GBCB 5874: Problem Solving in GBCB

Structural Bioinformatics (C3210) Molecular Docking

FRAUNHOFER IME SCREENINGPORT

Priority Setting of Endocrine Disruptors Using QSARs

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller

Early Stages of Drug Discovery in the Pharmaceutical Industry

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a

JCICS Major Research Areas

Structure-Activity Modeling - QSAR. Uwe Koch

Ignasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression

Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007

In Silico Investigation of Off-Target Effects

CH MEDICINAL CHEMISTRY

Computer Graphics Applications on Molecular Biology and Drug Design

Plan. Day 2: Exercise on MHC molecules.

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre

Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs

MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination.

Quantitative structure activity relationship and drug design: A Review

LigandScout. Automated Structure-Based Pharmacophore Model Generation. Gerhard Wolber* and Thierry Langer

Introduction. OntoChem

Fondamenti di Chimica Farmaceutica. Computer Chemistry in Drug Research: Introduction

Nonlinear QSAR and 3D QSAR

Course Plan (Syllabus): Drug Design and Discovery

Advanced Medicinal Chemistry SLIDES B

Using AutoDock for Virtual Screening

5.1. Hardwares, Softwares and Web server used in Molecular modeling

Topology based deep learning for biomolecular data

Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,..

Solved and Unsolved Problems in Chemoinformatics

Cheminformatics platform for drug discovery application

Integrated Cheminformatics to Guide Drug Discovery

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME

Quantitative Structure-Activity Relationship (QSAR) computational-drug-design.html

Chemoinformatics and information management. Peter Willett, University of Sheffield, UK

Drug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters

EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS

Cheminformatics Role in Pharmaceutical Industry. Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS

Computational chemical biology to address non-traditional drug targets. John Karanicolas

Virtual affinity fingerprints in drug discovery: The Drug Profile Matching method

Molecular Modeling Study of Some Anthelmintic 2-phenyl Benzimidazole-1- Acetamides as β-tubulin Inhibitor

Structure-Based Drug Discovery An Overview

CSD. CSD-Enterprise. Access the CSD and ALL CCDC application software

Notes of Dr. Anil Mishra at 1

Machine learning for ligand-based virtual screening and chemogenomics!

Cross Discipline Analysis made possible with Data Pipelining. J.R. Tozer SciTegic

Data Mining in the Chemical Industry. Overview of presentation

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit

Thermodynamic Integration with Enhanced Sampling (TIES)

Virtual screening in drug discovery

Lecture for Molekylär bioinformatik X3 Feb Computational Chemistry in Drug Discovery. Mats Kihlén. Head of Research Informatics.

PROVIDING CHEMINFORMATICS SOLUTIONS TO SUPPORT DRUG DISCOVERY DECISIONS

Practical QSAR and Library Design: Advanced tools for research teams

Biologically Relevant Molecular Comparisons. Mark Mackey

Exploring the black box: structural and functional interpretation of QSAR models.

bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining

Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design

Chemoinformatics and Drug Discovery

ENERGY MINIMIZATION AND CONFORMATION SEARCH ANALYSIS OF TYPE-2 ANTI-DIABETES DRUGS

Supplementary Methods

RATIONAL DRUG DESIGN

What is a property-based similarity?

Introduction to Chemoinformatics

Knowledge instead of ignorance. More efficient drug design through the understanding of experimental uncertainty

Building innovative drug discovery alliances. Just in KNIME: Successful Process Driven Drug Discovery

Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery

Ping-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.

Artificial Intelligence Methods for Molecular Property Prediction. Evan N. Feinberg Pande Lab

A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery

Synthetic organic compounds

MODELING AND INFORMATICS IN DRUG DESIGN. National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, India

Softwares for Molecular Docking. Lokesh P. Tripathi NCBS 17 December 2007

NMR Solutions for drug discovery

Keywords: anti-coagulants, factor Xa, QSAR, Thrombosis. Introduction

Drug Discovery. Zainab Al Kharusi Office: 33-10

Molecular Modelling for Medicinal Chemistry (F13MMM) Room A36

Interactive Feature Selection with

CHAPTER 6 QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) ANALYSIS

Bridging the Dimensions:

Implementation of novel tools to facilitate fragment-based drug discovery by NMR:

Similarity Search. Uwe Koch

Moscow Institute of Physics and Technology, Institutsky 9, Dolgoprudny , Russia 2

Synthetic organic compounds

Driving Serendipity: the Era of Active Ingredients Discovery. Valentina Sedini Scientific Marketing

Drug Informatics for Chemical Genomics...

Joana Pereira Lamzin Group EMBL Hamburg, Germany. Small molecules How to identify and build them (with ARP/wARP)

Saba Al Fayoumi. Tamer Barakat. Dr. Mamoun Ahram + Dr. Diala Abu-Hassan

Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface

CHAPTER 3. Pharmacophore modelling studies:

Hit Finding and Optimization Using BLAZE & FORGE

Transcription:

In silico pharmacology for drug discovery

In silico drug design In silico methods can contribute to drug targets identification through application of bionformatics tools. Currently, the application of computers and computation methods encompasses all aspects of drug discovery; they represent the fundamentals of the structure-based drug design. The main roles of the computation techniques in drug discovery are: Virtual screening and de novo design; In silico ADME/Tох prediction; Advanced methods for determining protein - ligand binding.

The importance of in silico drug design The structures of the most protein targets become accessible through the use of crystallography, NMR, bioinformatics methods, etc. The search of computational tools that can identify and analyze the active binding sites and determine what type of potential drug molecules can specifically bind to these sites. Application in combating life-threatening diseases like AIDS, malaria, tuberculosis, etc.

In silico methods for drug detection Molecular docking; Virtual screening; QSAR (Qualitative Structure - Activity Relationship); Pharmacophore mapping; Fragments-based screening.

Molecular docking Molecular docking is a computational determination of the binding affinity between molecules (target and ligand). It is imperative to understand the free energy of the complex formed by their docking.

Molecular docking: classification Molecular docking or automated computational systems for drug design can be classified as follows: Receptor-based methods they use the structure of the target protein Ligand-based methods grounded on known inhibitors

Receptor-based methods Use the 3D structure of the target receptor for searching of potential candidate compounds that can modulate the target function. They include molecular docking of any compound in chemical data bases in the binding site of the target and prediction of the electrostatic matching between them. The compounds are ordered using appropriate dot function, thus the results correlate with the binding affinity. The receptor-based methods are applied successfully to many different target molecules.

Ligand-based strategy When information about the target structure is lacking, the ligand-based method is using the information for the known inhibitors of the target receptor. Structures, similar to the known inhibitors are identified in the chemical data bases using different methods. Some of the widely used methods are: similarity, sub-structure search, pharmacophore matching or matching of the 3D format. Many successful applications of the ligandbased methods are reported.

Virtual screening The Virtual Screening (VS) is a computational technique used for drug discovery that is based on search in small molecules libraries for identification of those structures that are most probably bound to the drug target, usually protein receptor or enzyme. The Virtual Screening is defined as an automatic evaluation of large libraries of compounds using computer programmes. There are two main categories of creening techniques: ligand-based and structurebased.

Ligand-based virtual screening Keeping in mind that ligands with different structures can bind to the receptor, a model of the receptor can be built using the collected information regarding this set of ligands. These models are known as pharmacophore models. The candidate-ligand can be compared with the pharmacophore model for determination of its compatibility with the model, and consequently its ability to bind to it.

Structure-based Virtual Screening Structure-based virtual screening comprises docking of the candidate-ligands to the target protein followed by application of dotting function for evaluation of the high-affinity binding probability of the ligand to the protein. Web servers oriented towards potential virtual screening are freely available.

Qualitative Structure - Activity Relationships (QSARs) QSARs are mathematical relationships that interrelate chemical structures with biological activity using physical-chemical and other properties obtained as an interface. Biological activity = f (physical-chemical properties) The physical-chemical and any other property used for generation of QSARs are notified as descriptors and are treated as an independent variable. The biological property is treated as dependent variable.

Types of QSARs 2D QSAR Two-dimentional molecular properties 3D QSAR Three-dimentional molecular properties Analysis of molecular field Analysis of molecular form Analysis of geometrical distance Analysis of receptor surface

Pharmacophore mapping Pharmacophore is an abstract description of molecular characteristics that are needed for molecular recognition of the ligand by the biological macromolecule. This is a 3D description of the pharmacophore developed for specification of the nature of the key characteristics of the pharmacophore, and 3D mapping of the distance among all those characteristics. Pharmacophore maps can be generated by the superposition of the active compounds for identification of their common characteristics. On the basis of the pharmacophore maps either de novo design or 3D searching in the data bases can be performed.

Fragment-based screening The fragment-based screening is gaining more and more popularity during the last decade and is proved to be reliable alternative of the high throughput screening. Fragments space" is smaller than the chemical space" and can be more effectively studied with relatively smaller libraries.

In vitro and in vivo ADME/TOX models ADME is an abbreviation in pharmacokinetics and pharmacology for adsorption, distribution, metabolism and excretion" and it describes the positioning of a pharmaceutical in the organism. The four criteria influence the drug levels and kinetics of its exposition in the tissues and in this way, they influence the action and the pharmacological activity of a certain compound as a drug. These methods can be applied in vitro, using cell tissues, or in silico using computational models. Sometimes the potential or the real toxicity of a compound are also considered (ADME-Tox or ADMET). The computational chemists are trying to predict the ADME-Tox properties of the compounds using QSPR or QSAR methods.

CoMFA (Comparative Molecular Field Analysis) CoMFA (Comparative Molecular Field Analysis) is a 3D QSAR technique based on the data for known active molecules. CoMFA is often applied when the 3D structure of the receptor is unknown. How does CoMFA work? The active molecules are placed in three-dimentional net (2-distance), that encompasses all molecules. The steric energy (Lenard-Johns potential) and the electrostatic energy of each molecule are measured at any point of the net using atomic probe (SP3-hybridized C atom +1 charge). To minimize the domination of the large steric and electrostatic energies all data that exceed a defined value (30 kcal/moll) are adjusted at a trash-hold value. CoMFA partly uses the Partial least squares regression (PLS) to predict activity on the basis of the energy values in the net points.

Molecular Dynamics (MD) The Molecular Dynamics is a computational simulation method for studying the physical movements of the atoms and the molecules. Since the molecular systems commonly are composed by a large number of particles it is not possible the properties of such complex systems to be determined by analytical methods. The МD simulation solves this problem using computational methods. However, the long MD simulations are not exact and generate cumulative errors in the numerical integration. They can be minimized by careful selection of algorithms and parameters but can not be fully eliminated. The method is initially developed within the theoretical physics area in the late 1950 but it is still applied nowadays mostly in physical-chemistry, material science and biomolecules modeling.

Thank you for your attention